Abstract: The present invention relates to the use of specific carboxy compounds, more specifically to the use of 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride, in the treatment of inflammatory diseases. Part of the invention is also a composition, preferably a pharmaceutical composition, comprising as active ingredient at least 2 (4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride together with (pharmaceutically) acceptable excipients.
Type:
Grant
Filed:
June 21, 2002
Date of Patent:
May 30, 2006
Assignee:
Gent Universiteit
Inventors:
Karolien De Bosscher, Wim Vanden Berghe, Guy Haegeman